Six patients with severe and complicated falciparum malaria (6.7 +/- 2
.7 WHO criteria) were admitted to our Intensive Care Unit. All patient
s acquired the disease while travelling in tropical Africa without app
ropriate chemoprophylaxis. The clinical manifestations included hyperp
yrexia (all patients), chills (4), sweating (2), asthenia (3), anorexi
a (2), headache (1), arthralgias (1), vomiting (4), diarrhoea or abdom
inal discomfort (3), jaundice (2) and disturbances of consciousness (4
). All patients had anemia, thrombocytopenia, hyponatremia, hypoprotei
nemia, hypoalbuminemia, hypocalcemia and acute renal failure, in one c
ase associated with anuria. A low grade parasitemia was observed in tw
o patients and a high grade parasitemia (20%-58% of erythrocytes) in f
our. Exchange transfusion was performed only in high parasitemic patie
nts and ail of them survived. All patients were treated with quinine,
a sulfonamide and pyrimethamine. Additionally, five patients received
oxytetracycline, doxycycline or clindamycin. Three patients required h
emodyalisis. Five patients had delirium, coma or seizures. All patient
s had at least one sign of hepatic impairment: liver enlargement, jaun
dice or increased bilirubin or aminotransferase levels. Two patients h
ad spleen enlargement. Laboratory findings suggested disseminated intr
avascular coagulation in four patients. Four patients developed pulmon
ary changes and three of them required mechanical ventilation. A Swan-
Ganz catheter was placed in four patients. In three of them (two with
pulmonary edema) the pulmonary capillary wedge pressure was initially
increased, which suggested a cardiogenic or hypervolemia mechanism, bu
t soon returned to normal level. One patient with low grade parasitemi
a died because of adult respiratory distress syndrome after 18 days. I
n our series, the degree of parasitemia was not related to the severit
y of the disease.